DOI: 10.4244/EIJV7I9A177

Tools & Techniques: Above the knee angioplasty by transradial access

Roberto Lorenzoni*, MD, FESC; Cristiano Lisi, MD; Mauro Lazzari, MD; Francesco Bovenzi, MD

Background

Above the knee (ATK) angioplasty is usually performed via transfemoral access employing the crossover technique. When, occasionally, the crossover approach cannot be pursued due to anatomic constraints, the transbrachial access has been used as an alternative. However, transbrachial access is associated with frequent complications, especially when used by operators not familiar with this approach.

Transradial access (TRA) is being increasingly employed for percutaneous coronary interventions. Until now, angioplasty on ATK arteries by TRA has been limited by the inadequate length of available devices, though recently, longer devices have become available. The aim of this paper is to describe the materials and techniques for a successful ATK angioplasty by TRA.

Indications

TRA can be used for ATK angioplasty as the alternative to a difficult transfemoral access. However, TRA could become a routine access for treating intrastent restenosis (Figure 1A and Figure 1B) or addressing bilateral lesions within the same session.

Figure 1. The patient, 78-year-old, presented with a recurrence of left claudication, Rutherford category 2, intrastent restenosis 10 months after stenting of his left SFA (A) The left common iliac artery was engaged with a 125 cm long, 6 Fr guiding catheter (Multipurpose; Cordis, Johnson & Johnson, Warren, NJ, USA) by left TRA; the lesion was crossed with a 400 cm long, 0.018”, soft tip wire (Plywire; OptiMed, Ettlingen, Germany); (B) the stenosis was successfully dilated with a 0.018”-compatible 5.0/120 mm balloon (Pacific Extreme; Medtronic, Minneapolis, MN, USA).

Difficulties

We use a 120 cm introducer system for steadily engaging the iliac arteries and 300-400 cm long wires (variably performing) to cross the lesions themselves. In our armamentarium are balloons and stents with 180 cm long shafts to dilate lesions and cover flow-limiting dissections. On the contrary, today we still lack support catheters longer than 150 cm to aid the progression of these wires and to cross the lesions. Finally, debulking and crossing systems need to be developed with long shafts for approaching long and calcified lesions, or aggressive intrastent restenosis.

Methods

For treating ATK vessels by TRA, the left radial artery is to be preferred because the path to the aortic bifurcation is shorter. There are three options to select the common iliac arteries by TRA. First, the radial artery can be cannulated with a 6 Fr radial introducer, the common iliac arteries can then be engaged with a125 cm long, 6 Fr guiding catheter (Multipurpose; Cordis, Johnson & Johnson, Warren, NJ, USA). A second option is to use a120cm long, 5 Fr sheath (Epsylar; OptiMed, Ettlingen, Germany). A third option is to employ a 120 cm long, 8.5 Fr sheathless guiding catheter (SheathLess PV; Asahi Intecc, Aichi, Japan).

For ATK angioplasty, only 0.018”, 300 cm long wires can be used (e.g., V18; Boston Scientific, Natick, MA, USA; Treasure 12 and Astato 30; Asahi Intecc, Aichi, Japan). As soon as the lesion is crossed, these aggressive wires can be exchanged and position maintained with a 400 cm long, soft tip wire (Plywire; OptiMed, Ettlingen, Germany).

At the present time there are two over-the-wire, 0.018” compatible balloons with a 180 cm long shaft: Dilexx-18 (OptiMed) and Pacific Extreme (Medtronic).

Finally, in order to cover flow-limiting dissections, the OptiMed sinus-SuperFlex-518 is the only self-expanding nitinol stent system with a 180 cm long shaft. For treating ostial common iliac arteries lesions, balloon-expandable stents with a 135 cm long shaft usually suffice (OMNILINK Elite; Abbott, Abbott Park, Il, USA).

Conflict of interest statement

The authors have no conflict of interest to declare.

Volume 7 Number 9
Jan 20, 2012
Volume 7 Number 9
View full issue


Key metrics

On the same subject

Editorial

10.4244/EIJ-E-24-00010 Apr 15, 2024
Timing of revascularisation in acute coronary syndromes with multivessel disease – two sides of the same coin
Stähli B and Stehli J
free

Editorial

10.4244/EIJ-E-24-00016 Apr 15, 2024
Can artificial intelligence help Heart Teams make decisions?
Koch V
free

Editorial

10.4244/EIJ-E-24-00006 Apr 15, 2024
The miracle of left ventricular recovery after transcatheter aortic valve implantation
Dauerman H and Lahoud R
free

State-of-the-Art

10.4244/EIJ-D-23-00836 Apr 15, 2024
Renal denervation in the management of hypertension
Lauder L et al
free

Research Correspondence

10.4244/EIJ-D-23-01046 Apr 15, 2024
Feasibility and safety of transcaval venoarterial extracorporeal membrane oxygenation in severe cardiogenic shock
Giustino G et al
Trending articles
337.88

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
283.98

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
226.03

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
209.5

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.4

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
150.28

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
103.48

Expert consensus

10.4244/EIJ-E-22-00018 Dec 4, 2023
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved